Murase, J. E. ., Munera-Campos, M. ., Hong, H. C.- ho ., Taieb, A. ., Chung, W.-H. ., Reck Atwater, A., Rueda, M. J. ., Zhong, J. ., Buziqui Piruzeli, M. L. ., Pau-Charles, I. ., & Deleuran, M. . (2023). Lebrikizumab-Treated Patients With Atopic Dermatitis Had No Increase in Treatment-Emergent Adverse Events of Facial, Head, and Neck Erythema Compared to Placebo. SKIN The Journal of Cutaneous Medicine, 7(6), s272. https://doi.org/10.25251/skin.7.supp.272